Eric Topol on Nostr: Very good news on the fall booster. The FDA changed course from JN.1 to select KP.2, ...

Very good news on the fall booster. The FDA changed course from JN.1 to select KP.2, which in the animal model has a >3-fold induction of neutralizing antibodies vs KP.3, the SARS-CoV2 variant that is on its way to dominance in the US (and causing trouble in multiple countries)
https://www.nbcnews.com/health/health-news/fda-recommends-covid-vaccine-update-target-kp2-strain-rcna157089